Oxacillin (Bactocill) Injection - Uses, Dosage, Side effects, Brands

Oxacillin (Bactocill) is penicillinase-resistant penicillin (beta-lactam antibiotic) used in the treatment of susceptible gram-positive infections.

Oxacillin Uses:

  • Staphylococcal infections:

    • Used for treatment of infections caused by penicillinase-producing staphylococci that have demonstrated susceptibility to the drug.
    • In suspected cases of resistant staphylococcal infections, empiric therapy.
  • Limitations of use:

    • Oxacillin should not be used in infections caused by organisms susceptible to penicillin G. Use
  • Off-Label:

    • Adult Catheter-related bloodstream infections.
    • Skin and soft tissue necrotizing infections.
    • Surgical site infections.

Oxacillin Dose in Adults

Note:

  • May have a significant amount of sodium.
  • Consult product-specific labeling for the amount.

Oxacillin Dose in the treatment of Catheter-related bloodstream infections (off-label use):

  • IV:
  • 2 g after every 4 hours (Mermel 2009)

Oxacillin Dose in the treatment of Endocarditis:

  • Methicillin-susceptible Staphylococcus aureus (MSSA) (off-label dose; AHA [Baddour 2015]):

  • IV:

    • Native valve endocarditis:

      • For 6 weeks, 12 g per day in 4 or 6 divided doses (ie, 2 g every 4 hours or 3 g every 6 hours).
    • Note:
      • Dosing intended for complicated right-sided infective endocarditis (IE) or left-sided IE.
      • 2 weeks of therapy may be adequate, for uncomplicated right-sided IE.
    • Prosthetic valve endocarditis:

      • For at least 6 weeks, 12 g per day in 6 divided doses (ie, 2 g every 4 hours) (use with rifampin for the entire course and gentamicin for first 2 weeks)

Oxacillin Dose in the treatment of Meningitis, bacterial: Methicillin-susceptible S. aureus: (off-label dose):

  • IV:

    • 2 g every 4 hours.
    • If the organism is susceptible and prosthetic material is present, consider the addition of rifampin.

Oxacillin Dose in the treatment of Osteomyelitis, native vertebral (off-label dose):

  • Staphylococcus (oxacillin-susceptible):

    • IV:
    •  For 6 weeks, 1.5-2 g every 4-6 hours or via continuous infusion.

Oxacillin Dose in the treatment of prosthetic joint infection:

  • IV:
  • With rifampin, 2 g every 4 hours

Dose in the treatment of methicillin-susceptible Staphylococcus aureus infections:

  •  Including
    • brain abscess,
    • bursitis,
    • erysipelas,
    • mastitis,
    • mastoiditis,
    • osteomyelitis,
    • perinephric abscess,
    • pneumonia,
    • pyomyositis,
    • scalded skin syndrome, and
    • toxic shock syndrome:
  • IV:
  • 2 g every 4 hours

Oxacillin Dose in the treatment of Skin and soft tissue infections:

IV:

  • Due to methicillin-susceptible Staphylococcus aureus (MSSA):

    • For 7 to 14 days, 1 to 2 g every 4 hours

Oxacillin Dose in the treatment of Necrotizing infection due to MSSA (off-label):

  • Every 4 hours, 1 to 2 g
  • Until further debridement is not necessary, continue, the patient has clinically improved, and the patient is afebrile for 48-72 hours

Oxacillin Dose in the treatment of Surgical site infections (trunk or extremity away from axilla or perineum) (off-label):

  • IV:
  • 2 g every 6 hours (IDSA [Stevens 2014])

Oxacillin Dose in Childrens

Oxacillin General dosing in susceptible infection:

  • Mild to moderate infections:

    • Infants, Children, and Adolescents IM/ IV:
      • Every 6 hours, 100-150 mg/kg/day in divided doses.
      • Max daily dose: 4,000 mg per day
  • Severe infections:

    • Infants, Children, and Adolescents (IM//IV):
      • Every 4 to 6 hours, 150-200 mg/kg/day in divided doses.
      • Max daily dose:
      • 12 g per day

Oxacillin Dose in the treatment of Endocarditis:

  • Children and Adolescents (IV):

    •  Every 4 to 6 hours, 200 mg/kg/day in divided doses.
    • Max daily dose:
    • 12 g per day.
    • Treat for at least four weeks.
    • Extended durations may be needed.
    • May use in combination with gentamicin for some resistant organisms.

Oxacillin Dose in the treatment of Meningitis and Ventriculitis:

  • Infants, Children, and Adolescents (IV):

    • Every 6 hours, 200 mg/kg/day in divided doses.
    • Max daily dose:
    • 12 g per day (IDSA [Tunkel 2004]; IDSA [Tunkel 2017])

Oxacillin Dose in the treatment of community-acquired (CAP) moderate to severe infection S. aureus (methicillin-susceptible) Pneumonia:

  • Infants >3 months, Children, and Adolescents (IV):

    • Every 6 to 8 hours, 150-200 mg/kg/day divided (IDSA/PIDS [Bradley 2011])

Oxacillin Dose in the treatment of Skin and soft tissue infections:

  • Infants, Children, and Adolescents:

    • Methicillin-susceptible Staphylococcus aureus (MSSA) IV:

      • Every 6 hours, 100-150 mg/kg/day in divided doses.
      • Max daily dose:
      • 12 g per day
    • Necrotizing infection due to MSSA (IV):

      • Every 6 hours, 200 mg/kg/day in divided doses.
      • Max daily dose:
      • 12 g per day.
    • Continue until further debridement is not necessary, the patient has clinically improved, and the patient is afebrile for 48-72 hours.

Oxacillin Pregnancy risk Category: B

  • Oxacillin is absorbed into the amniotic fluid and detected in cord blood.
  • Penicillin use by mothers has not been linked to an increase in the risk of adverse effects on fetal health.

Use of Oxacillin while breastfeeding

  • Breast milk contains Oxacillin.
  • The manufacturer suggests that nursing mothers be cautious when administering oxacillin.
  • These effects may not be related to the dosage.

Oxacillin Dose in Kidney Disease:

  • In the manufacturer's labeling, there are no dosage adjustments provided.
  • However, if renal impairment is known or suspected, the manufacturer suggests considering a reduction in total dosage.

Oxacillin Dose in Liver Disease:

  • In the manufacturer's labeling, there are no dosage adjustments provided.

Side effects of Oxacillin:

  • Gastrointestinal:

    • Clostridioides Difficile Associated Diarrhea
    • Clostridioides Difficile Colitis
  • Hepatic:

    • Hepatotoxicity
    • Increased Serum Aspartate Aminotransferase
  • Renal:

    • Acute Interstitial Nephritis
    • Acute Renal Tubular Disease

Contraindications to Oxacillin:

  • Hypersensitivity (eg anaphylaxis), to any penicillin or any component of the formulation.

Warnings and precautions

  • Anaphylactic and hypersensitivity reactions

    • Patients who have received penicillin therapy for severe and sometimes fatal hypersensitivity reactions (anaphylactic) have been diagnosed.
    • This includes patients with a history beta-lactam hypersensitivity, multiple allergies history, or IgE-mediated reactions such as anaphylaxis (eg, angioedema, allergic urticaria).
    • Patients with history of severe allergies or asthma should be cautious.
    • Stop using the medication if you experience an allergic reaction and seek out appropriate treatment.
  • Hepatitis

    • Acute hepatitis can sometimes be accompanied by leukopenia and rash. Reversible elevations in serum transaminases may also be reported.
    • After 2-3 weeks of therapy, symptoms will begin to appear.
    • Examine regularly during therapy.
  • Superinfection

    • Extended use can lead to fungal or bacterial overinfections, such as C. difficile-associated diarrhea(CDAD) and pseudomembranous collitis.
    • CDAD was observed for >2 months after antibiotic treatment.
  • Renal impairment

    • Be careful.
    • Recommendation to adjust dosage.

Oxacillin: Drug Interaction

Risk Factor C (Monitor therapy)

Acemetacin

May increase the serum concentration of Penicillins.

BCG Vaccine (Immunization)

Antibiotics may diminish the therapeutic effect of BCG Vaccine (Immunization).

Lactobacillus and Estriol

Antibiotics may diminish the therapeutic effect of Lactobacillus and Estriol.

Methotrexate

Penicillins may increase the serum concentration of Methotrexate.

Mycophenolate

Penicillins may decrease serum concentrations of the active metabolite(s) of Mycophenolate. This effect appears to be the result of impaired enterohepatic recirculation.

Probenecid

May increase the serum concentration of Penicillins.

Vitamin K Antagonists (eg, warfarin)

Penicillins may enhance the anticoagulant effect of Vitamin K Antagonists.

Risk Factor D (Consider therapy modification)

Sodium Picosulfate

Antibiotics may diminish the therapeutic effect of Sodium Picosulfate. Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.

Tetracyclines

May diminish the therapeutic effect of Penicillins.

Typhoid Vaccine

Antibiotics may diminish the therapeutic effect of Typhoid Vaccine. Only the live attenuated Ty21a strain is affected. Management: Vaccination with live attenuated typhoid vaccine (Ty21a) should be avoided in patients being treated with systemic antibacterial agents. Use of this vaccine should be postponed until at least 3 days after cessation of antibacterial agents.

Risk Factor X (Avoid combination)

BCG (Intravesical)

Antibiotics may diminish the therapeutic effect of BCG (Intravesical).

Cholera Vaccine

Antibiotics may diminish the therapeutic effect of Cholera Vaccine. Management: Avoid cholera vaccine in patients receiving systemic antibiotics, and within 14 days following the use of oral or parenteral antibiotics.

Monitoring Parameters:

  • During the first dose, observe for signs and symptoms of anaphylaxis.
  • Examine periodic CBC, urinalysis, BUN, serum creatinine, AST and ALT,

How to administer Oxacillin?

IV:

  • Administer IVP over 10 mins or IVPB (IV piggyback) over 30 mins.

Mechanism of action of Oxacillin:

  • One or more penicillin-binding protein (PBPs) inhibits bacterial cell cell wall synthesis by binding.
  • This in turn inhibits the final step of peptidoglycan transpeptidation in bacterial cells walls and thus, inhibits cell wall biosynthesis.
  • Despite the fact that cell wall assembly is stopped, bacteria eventually lyses due to the ongoing activity of cell-wall autolytic enzymes (autolysins and murein hydrolases).

Distribution:

  • Into bile, amniotic, and pleural fluids.
  • In CSF and aqueous humor, insignificant concentrations

Protein binding:

  • ~94 percent (mainly albumin)

Metabolism:

  • Hepatic

Half-life elimination:

  • Neonates (PNA: 8-15 days):
    • 1.6 hours
  • Infants and Children ≤2 years:
    • 0.9-1.8 hours
  • Adults:
    • 20-30 mins.
    • Prolonged with renal impairment

Time to peak serum concentration:

  • IM:
    •  30 mins
  • IV:
    • 5 mins

Excretion:

  • Urine and bile (unchanged drug)

International Brands of Oxacillin:

  • Bactocill in Dextrose
  • Biotam
  • Bristopen
  • Cloxacap
  • Cloxcin
  • Minzil
  • Ocillina
  • Ocina
  • Oxacilina
  • Oxacillin
  • Oxan
  • Oxanon
  • Oxapen
  • Oxatalis
  • Penstapho
  • Procillin
  • Prostafilina
  • Prostaphlin
  • Stapenor
  • Syntarpen
  • Wydox

Oxacillin Brand Names in Pakistan:

No Brands Available in Pakistan.

Comments

NO Comments Found